1 completed, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Ceftazidime-avibactam: new trials by email Literature Review of Ceftazidime-avibactam trials Research Report on Ceftazidime-avibactam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single-dose PK Study of Ceftazidime-Avibactam In Hospitalized Children Receiving Systemic Antibiotics for Nosocomial Pneumonia Ceftazidime-avibactam - Hospitalized Children With Suspected or Confirmed Nosocomial Pneumonia | Phase 1 | Terminated | Pfizer | 4 | 2020-06-15 | 2022-09-09 |
| A Trial to Evaluate the Pharmacokinetics and Safety of AVYCAZ(R) in Combination With Aztreonam AZACTAM, Ceftazidime-Avibactam - Bacterial Infection | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 48 | 2019-07-09 | 2022-06-07 |
Bacterial Infections (1) · Healthcare-Associated Pneumonia (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1) · Pfizer (1)
China (1) · Taiwan (1) · United States (1)
2018 (1), 5UM1AI104681-09 (1)